Clinical immunology (Orlando, Fla.)Graft vs Host DiseaseHumansLeukemia Inhibitory FactorAnimalsHematopoietic Stem Cell Transplantation
Leukemia inhibitory factor (LIF) in acute graft-versus-host disease: A hypothesis-generating review.
Ahmad Meshkin, Fateme Zare, Mohammad Erfan Abbasi, Maryam Sadat Montazeri, Fatemeh Badiee, Mohammad Masoud Khodaei
Published: 202610.1016/j.clim.2025.110640
Abstract
Leukemia inhibitory factor (LIF) is a multifunctional cytokine of the IL-6 family, originally identified in murine leukemia cells. Graft-versus-host disease (GvHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HS…
Preview only. Read the full abstract at the source